Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Therapy data

From: Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer

Surgery and concomitant therapy
  n %
Patients with incomplete (primary) surgery 4 10.3
Patients with surgical nodal staging 11 28.2
Clinical nodal staging 28 71.8
Complete chemotherapy (Cisplatin 40 mg/m2 weekly) 31 79.5
Patients without all cycles of chemotherapy due to hematological toxicities 3 7.7
Patients without chemotherapy due to contraindication or refusal 5 12.8
Radiotherapy dosage
  Median (Gy) Range (Gy)
Radiotherapy duration (days) 60 46 - 96
EBRT elective pelvic nodal dose (Gy) 50.4 45-55.8
EBRT elective paraaortral dose (Gy) 47.7 45 - 50.4
EBRT Tumor Boost dose (Gy) 9 5.4 - 21.6
EBRT Total Tumor Dose (Gy) 59.4 50.4 - 72
LN Boost dose (Gy) 62 59.4 - 64.8
Brachytherapy total dose (Gy) 18 10 - 24
Brachytherapy single dose (Gy) 6 5-6